News
CMOPF
67.10
NaN%
--
Weekly Report: what happened at CMOPF last week (0914-0918)?
Weekly Report · 5h ago
Cosmo’s GI Genius AI System Boosts Adenoma Detection in Major VA Study
TipRanks · 10h ago
Largest Real-World Study of the GI Genius(TM) Intelligent Endoscopy System Demonstrates Improved Adenoma Detection in Routine Clinical Practice
Newsfile · 10h ago
Weekly Report: what happened at CMOPF last week (0907-0911)?
Weekly Report · 09/14 10:35
Weekly Report: what happened at CMOPF last week (0831-0904)?
Weekly Report · 09/07 10:27
Weekly Report: what happened at CMOPF last week (0824-0828)?
Weekly Report · 08/31 10:35
Weekly Report: what happened at CMOPF last week (0817-0821)?
Weekly Report · 08/24 10:36
Weekly Report: what happened at CMOPF last week (0810-0814)?
Weekly Report · 08/17 10:37
Cosmo Pharmaceuticals to Change SIX Ticker to CMHC, Aligning Brand With Health-Focused Strategy
TipRanks · 08/14 05:32
Cosmo Announces SIX Ticker Symbol Change to "CMHC"
Newsfile · 08/14 05:22
Weekly Report: what happened at CMOPF last week (0803-0807)?
Weekly Report · 08/10 10:31
Weekly Report: what happened at CMOPF last week (0727-0731)?
Weekly Report · 08/03 10:31
Weekly Report: what happened at CMOPF last week (0720-0724)?
Weekly Report · 07/27 10:36
Cosmo N.V. GAAP EPS of -€0.28, revenue of €50.24M
Seeking Alpha · 07/23 17:29
Cosmo lifts recurring revenues and advances dermatology and GI pipelines
TipRanks · 07/23 05:34
Cosmo Reports Double-Digit Recurring Revenue Growth in H1 2026, Advances Clascoterone 5% Topical Solution Toward Regulatory Submission, and Confirms Full-Year Guidance
Newsfile · 07/23 05:01
Weekly Report: what happened at CMOPF last week (0713-0717)?
Weekly Report · 07/20 10:32
Weekly Report: what happened at CMOPF last week (0706-0710)?
Weekly Report · 07/13 10:34
Weekly Report: what happened at CMOPF last week (0629-0703)?
Weekly Report · 07/06 10:38
Cosmo sets date for 2026 half-year results and investor webcast
TipRanks · 07/01 05:32
More
Webull provides a variety of real-time CMOPF stock news. You can receive the latest news about Cosmo Pharmaceuticals Nv through multiple platforms. This information may help you make smarter investment decisions.
About CMOPF
Cosmo N.V. formerly known as COSMO Pharmaceuticals N.V. is an Ireland based pharmaceutical company. The Company is focused on gastrointestinal (GI) diseases, dermatology, and healthtech. Its development pipeline includes Distal Ulcerative Colitis, Bile Acid Diarrhea, Solid Tumors, and AI Augmented Endoscopy. The Company's developed products include Lialda/Mezavant/Mesavancol and Uceris/Cortiment, which is used for the treatment of ulcerative colitis; GI Genius, which uses artificial intelligence to aid the detection of colorectal polyps during colonoscopy; Eleview, which is a submucosal injectable composition for use in gastrointestinal endoscopic procedures; Aemcolo, which is used for the treatment of travelers’ diarrhea (TD); Methylene Blue MMX, which is a diagnostic drug to improve precancerous and cancerous lesion detection during colonoscopy, and Winlevi, which is used for the treatment of acne. It also develops medical devices to assist with clinical decision-making.